Annexon presented new updates from its Guillain-Barré syndrome clinical program at the 27th annual Neuromuscular Study Group meeting. The company said it delivered four presentations on GBS research and related conditions.
published
Annexon presented new updates from its Guillain-Barré syndrome clinical program at the 27th annual Neuromuscular Study Group meeting. The company said it delivered four presentations on GBS research and related conditions.
Latest documented BWB result
BWB member result
Exit /ES with a huge win - 56 Points or 224 ticks
Historical results are not a promise of future performance. Trading involves substantial risk.This public post is a timestamped information archive, not personalized financial advice. Alerts can change as markets move. Join Billy's private group for the complete daily stream and follow-through.